161 related articles for article (PubMed ID: 3339724)
1. Flow cytometry deoxyribonucleic acid determinations and cytology of bladder washings: practical experience.
Klein FA; White FK
J Urol; 1988 Feb; 139(2):275-8. PubMed ID: 3339724
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometry followup of patients with low stage bladder tumors.
Klein FA; Whitmore WF; Herr HW; Melamed MR
J Urol; 1982 Jul; 128(1):88-92. PubMed ID: 7109078
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer.
Murphy WM; Emerson LD; Chandler RW; Moinuddin SM; Soloway MS
J Urol; 1986 Oct; 136(4):815-9. PubMed ID: 3761437
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of urinary cytology, and deoxyribonucleic acid flow cytometry and cytology on bladder washings during followup for bladder tumors.
Grégoire M; Fradet Y; Meyer F; Têtu B; Bois R; Bédard G; Charrois R; Naud A
J Urol; 1997 May; 157(5):1660-4. PubMed ID: 9112500
[TBL] [Abstract][Full Text] [Related]
5. DNA flow cytometry and bladder irrigation cytology in detection of bladder carcinoma.
Kumar NU; Dey P; Mondal AK; Singh SK; Vohra H
Diagn Cytopathol; 2001 Mar; 24(3):153-6. PubMed ID: 11241896
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of flow cytometry of bladder lavage in the surveillance of bladder tumors].
Hijazi A; Devonec M; Muchada E; Dubernard JM; Revillard JP
J Urol (Paris); 1987; 93(1):11-20. PubMed ID: 3559255
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of DNA flow cytometry and cytology of bladder washings: review of discordant cases.
Bakhos R; Shankey TV; Flanigan RC; Fisher S; Wojcik EM
Diagn Cytopathol; 2000 Feb; 22(2):65-9. PubMed ID: 10649514
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometry of low stage bladder tumors: correlation with cytologic and cystoscopic diagnosis.
Devonec M; Darzynkiewicz Z; Kostyrka-Claps ML; Collste L; Whitmore WF; Melamed MR
Cancer; 1982 Jan; 49(1):109-18. PubMed ID: 6172190
[TBL] [Abstract][Full Text] [Related]
9. Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by serial flow cytometry.
Badalament RA; Gay H; Whitmore WF; Herr HW; Fair WR; Oettgen HF; Melamed MR
Cancer; 1986 Dec; 58(12):2751-7. PubMed ID: 3779622
[TBL] [Abstract][Full Text] [Related]
10. Ancillary techniques in the followup of transitional cell carcinoma: a comparison of cytology, histology and deoxyribonucleic acid image analysis cytometry in 91 patients.
Mora LB; Nicosia SV; Pow-Sang JM; Ku NK; Diaz JI; Lockhart J; Einstein A
J Urol; 1996 Jul; 156(1):49-54; discussion 54-5. PubMed ID: 8648836
[TBL] [Abstract][Full Text] [Related]
11. Interphase cytogenetics as an adjunct in the cytodiagnosis of urinary bladder carcinoma. A comparative study of cytology, flow cytometry and interphase cytogenetics in bladder washes.
Cajulis RS; Haines GK; Frias-Hidvegi D; McVary K
Anal Quant Cytol Histol; 1994 Feb; 16(1):1-10. PubMed ID: 8011035
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometry for followup examinations of conservatively treated low stage bladder tumors.
Devonec M; Darzynkiewicz Z; Whitmore WF; Melamed MR
J Urol; 1981 Aug; 126(2):166-70. PubMed ID: 7021878
[TBL] [Abstract][Full Text] [Related]
13. Detection of bladder carcinoma in females by flow cytometry and cytology.
Hermansen DK; Badalament RA; Fair WR; Kimmel M; Whitmore WF; Melamed MR
Cytometry; 1989 Nov; 10(6):739-42. PubMed ID: 2582965
[TBL] [Abstract][Full Text] [Related]
14. [The diagnostic value of flow cytometric DNA analysis in bladder cancer--comparison with conventional cytology].
Kawasaki T
Hinyokika Kiyo; 1991 Nov; 37(11):1481-9. PubMed ID: 1767770
[TBL] [Abstract][Full Text] [Related]
15. Urine: a suitable sample for deoxyribonucleic acid flow cytometry studies in patients with bladder cancer.
deVere White RW; Deitch AD; Baker WC; Strand MA
J Urol; 1988 May; 139(5):926-8. PubMed ID: 3361665
[TBL] [Abstract][Full Text] [Related]
16. [Can the combination of bladder ultrasonography and urinary cytodiagnosis replace cystoscopy in the diagnosis and follow-up of tumors of the bladder?].
Cariou G; Maaraoui N; Cortesse A
Prog Urol; 1997 Feb; 7(1):51-5. PubMed ID: 9116739
[TBL] [Abstract][Full Text] [Related]
17. The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder.
Giella JG; Ring K; Olsson CA; Karp FS; Benson MC
J Urol; 1992 Aug; 148(2 Pt 1):293-6. PubMed ID: 1635121
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometry as a predictor of response and progression in patients with superficial bladder cancer treated with bacillus Calmette-Guerin.
Bretton PR; Herr HW; Kimmel M; Fair WR; Whitmore WF; Melamed MR
J Urol; 1989 Jun; 141(6):1332-6. PubMed ID: 2724430
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometry versus urinary cytology in the diagnosis and follow-up of bladder tumors: critical review of a 5-year experience.
Billerey C; Lamy B; Bittard H; Rozan S; Carbillet JP
World J Urol; 1993; 11(3):156-60. PubMed ID: 8401634
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometry and cytology as response indicators to M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin).
Hermansen DK; Reuter VE; Whitmore WF; Fair WR; Melamed MR
J Urol; 1988 Dec; 140(6):1394-6. PubMed ID: 3193503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
